Diagnosing stage IV squamous cell carcinoma of the lung requires a combination of imaging studies, laboratory tests, and tissue analysis to confirm the disease and determine how far it has spread throughout the body.

Introduction: Who Should Undergo Diagnostics

If you have symptoms that might point to lung cancer, it’s important to seek medical attention promptly. Stage IV squamous cell lung cancer often reveals itself through persistent symptoms that don’t go away on their own. People who experience a cough that won’t disappear, chest pain, shortness of breath, or coughing up blood should talk to their doctor as soon as possible.^[3]

These warning signs can also include unexpected weight loss, loss of appetite, fatigue, and recurring chest infections such as bronchitis (inflammation of the airways) or pneumonia (infection of the lung tissue). Some patients notice hoarseness in their voice or wheezing when they breathe. Because squamous cell carcinoma typically develops in the central part of the lung near the main airways, symptoms may appear earlier compared to other types of lung cancer.^[8]

Screening is especially important for people at high risk. If you’re between 50 and older and have smoked heavily for many years, or if you quit smoking within the past 15 years, healthcare professionals may recommend yearly lung cancer screening using low-dose CT scans. This can help detect cancer before symptoms develop, when it might be easier to treat.^[5]

By the time squamous cell lung cancer reaches stage IV, it has already spread beyond the lungs to other parts of the body. This might include the other lung, lymph nodes, bones, brain, liver, or adrenal glands. At this advanced stage, patients may experience additional symptoms related to where the cancer has traveled. For example, if cancer reaches the brain, headaches, dizziness, or numbness in the limbs may occur. If it spreads to the liver, yellowing of the skin or eyes, known as jaundice, can develop.^[21]

Diagnostic Methods to Identify the Disease

Diagnosing squamous cell carcinoma of the lung typically begins with a detailed conversation between you and your doctor about your medical history. Your healthcare provider will ask about your symptoms, how long they’ve lasted, your smoking history, and whether you’ve been exposed to harmful substances like asbestos or radon. A physical examination follows, during which the doctor listens to your lungs and checks for signs of illness.^[20]

Imaging Tests

Once your doctor suspects lung cancer based on your symptoms and history, imaging tests are the next step. These tests create pictures of the inside of your body and help doctors see the location, size, and spread of any tumors. The most common imaging test used first is a chest X-ray, which can reveal abnormal masses or spots in the lungs. However, X-rays don’t always show small tumors or provide detailed information, so further testing is often needed.^[5]

Computed tomography (CT) scans are frequently used to get a more detailed look at the lungs. A CT scan uses X-rays taken from different angles and combines them with computer processing to create cross-sectional images of your body. This allows doctors to see the tumor more clearly, measure its size, and check whether it has spread to nearby lymph nodes or other structures in the chest. CT imaging is often the primary tool for evaluating squamous cell lung cancer, as long as the tumor is large enough to be detected.^[3]

Other imaging tests may be used to determine if cancer has spread to distant organs. Magnetic resonance imaging (MRI) uses magnets and radio waves instead of radiation to create detailed images, particularly useful for examining the brain or spinal cord. A positron emission tomography (PET) scan involves injecting a small amount of radioactive sugar into the body. Cancer cells, which use more sugar than normal cells, show up as bright spots on the scan, helping doctors identify areas where cancer may have spread.^[5]

Laboratory Tests and Sputum Analysis

Laboratory tests play an important role in lung cancer diagnosis. Blood tests can provide information about your overall health and how well your organs are functioning, which helps doctors plan treatment. While blood tests alone cannot diagnose lung cancer, they can reveal problems with the liver, kidneys, or other organs that might affect treatment choices.^[20]

Sputum cytology is a laboratory test in which doctors examine the mucus you cough up from your lungs under a microscope. If you’re coughing up sputum regularly, samples can be collected and analyzed to look for cancer cells. This test is simple and noninvasive, but it doesn’t always detect cancer, especially if the tumor is located deep in the lungs.^[3]

Biopsy Procedures

A biopsy is the most definitive way to diagnose squamous cell lung cancer. During a biopsy, a small sample of tissue is removed from the suspicious area and examined under a microscope by a specialist called a pathologist. The pathologist looks at the cells to determine whether they are cancerous and, if so, what type of lung cancer is present. There are several ways to perform a lung biopsy, depending on the tumor’s location and size.^[20]

One common method is bronchoscopy, in which a thin, flexible tube with a light and camera is inserted through your mouth or nose and down into your airways. The doctor can see inside your lungs and use small tools passed through the tube to collect tissue samples. Bronchoscopy is particularly useful for tumors located in or near the central airways, which is where squamous cell lung cancer often develops.^[3]

For tumors in the outer parts of the lungs that are harder to reach with a bronchoscope, a needle biopsy may be performed. Using imaging guidance, such as CT scans, the doctor inserts a thin needle through the chest wall to reach the tumor and extract a tissue sample. This procedure is usually done under local anesthesia, meaning you’re awake but the area is numbed so you don’t feel pain.

In some cases, doctors may need to perform more invasive procedures to obtain tissue samples. Mediastinoscopy involves making a small incision at the base of the neck and inserting a lighted tube to examine and biopsy lymph nodes in the chest. Another option is video-assisted thoracic surgery (VATS), a minimally invasive surgery using small incisions and a camera to visualize and biopsy areas inside the chest.^[20]

Immunohistochemistry and Cell Studies

Once tissue samples are collected, additional laboratory tests are performed to characterize the cancer cells more precisely. Immunohistochemistry is a technique that uses special stains to identify specific proteins on the surface of cancer cells. This helps doctors confirm that the cancer is squamous cell carcinoma and not another type of lung cancer. Accurate identification is essential because different types of lung cancer respond differently to treatment.^[3]

According to the World Health Organization, squamous cell lung carcinoma can be further classified into subtypes based on how the cells look under a microscope. These include keratinizing, nonkeratinizing, and basaloid squamous cell carcinoma. While these subtypes don’t always change the treatment approach, they provide doctors with more detailed information about the cancer.^[6]

Staging the Cancer

After confirming the diagnosis, doctors must determine the stage of the cancer, which describes how far it has spread. Staging helps guide treatment decisions and gives you and your doctor a better understanding of what to expect. In stage IV squamous cell lung cancer, the disease has spread to distant parts of the body. This is also called metastatic cancer, meaning it has traveled beyond its original location.^[5]

Doctors use a system called the TNM system to classify lung cancer. The “T” refers to the size and location of the tumor, “N” refers to whether cancer has spread to nearby lymph nodes, and “M” refers to whether it has metastasized to distant organs. These factors are combined to assign an overall stage. Stage IV means the cancer has spread to the other lung, the fluid around the lung or heart, or to distant organs such as the bones, liver, or brain.^[6]

Stage IV is further divided into stage IVA and stage IVB. Stage IVB indicates more widespread disease, with cancer found in multiple distant sites. Understanding the exact stage helps doctors choose the most appropriate treatment and estimate prognosis, although each person’s situation is unique.^[19]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or combinations of treatments to find better ways to manage lung cancer. For patients with stage IV squamous cell lung cancer, participating in a clinical trial may provide access to cutting-edge therapies that are not yet widely available. However, not everyone is eligible to join a clinical trial. Specific diagnostic tests and criteria are used to determine whether a patient qualifies.^[20]

One of the first requirements for clinical trial enrollment is confirmation of the cancer diagnosis through biopsy and pathology. Doctors must verify that you have squamous cell carcinoma of the lung and that it has reached stage IV. This involves reviewing your imaging studies, biopsy results, and staging information. Accurate staging is critical because many trials are designed for patients at a specific stage of disease.^[7]

Biomarker testing is another important component of clinical trial qualification. Biomarkers are substances in your body, such as genes or proteins, that can indicate how your cancer might behave or respond to treatment. For squamous cell lung cancer, researchers may test for specific genetic mutations or changes in the cancer cells. While certain mutations like EGFR or ALK are more commonly associated with other types of lung cancer, testing is still performed to ensure you receive the most personalized care possible.^[13]

Blood tests are routinely performed to assess your overall health and organ function before enrolling in a clinical trial. These tests check your blood cell counts, liver function, kidney function, and other important indicators. Clinical trials often have strict eligibility criteria, and patients must be healthy enough to tolerate the experimental treatment. For example, low blood counts or poor organ function might disqualify someone from a particular trial, even if their cancer stage matches the study’s requirements.^[20]

Imaging tests such as CT scans, PET scans, or MRI scans are repeated to establish a baseline before treatment begins. These images serve as a starting point for measuring how well the experimental treatment works. During the trial, doctors will compare new scans to the baseline images to see if the cancer has shrunk, stayed the same, or grown. This information helps researchers determine whether the treatment is effective.^[7]

Performance status is another key factor in clinical trial eligibility. Performance status is a measure of how well you can carry out daily activities and how much the cancer affects your physical abilities. Doctors use standardized scales to rate your performance status, and many trials require patients to have a certain level of functioning. If the cancer has significantly weakened you or caused severe symptoms, you might not meet the criteria for some trials.

Some clinical trials also require testing for specific biomarkers or genetic changes that make the experimental treatment more likely to work. For example, trials studying targeted therapies often enroll only patients whose cancer cells have certain mutations. Similarly, immunotherapy trials may test for biomarkers like PD-L1 expression, which indicates how much of a specific protein is present on cancer cells. Higher levels of PD-L1 may predict a better response to immunotherapy drugs.^[13]

Before joining a clinical trial, you’ll also undergo a thorough medical history review. Researchers need to know about any other health conditions you have, medications you’re taking, and previous cancer treatments you’ve received. Some trials exclude patients who have already tried certain therapies, while others are specifically designed for people whose cancer has progressed after standard treatments.

Throughout the trial, regular diagnostic tests are performed to monitor your response to treatment and watch for side effects. These may include blood tests, imaging studies, physical examinations, and quality-of-life questionnaires. The frequent monitoring ensures your safety and helps researchers collect the data needed to evaluate the new treatment’s effectiveness.